United States Government Publishing Office publisher pbl distributor dst United States Government Accountability Office author aut Government Organization text government publication eng GAOREPORTS Legislative Agency Publications gao_comptroller_general legislative 2016-06-24 U.S. Government Publishing Office 2005-01-18 monographic deposited born digital 8 p. GA 1.13:B-294944.2 https://www.govinfo.gov/app/details/GAOREPORTS-B-294944-2 P0b002ee18fd4c4b6 f:2949442 DGPO 2016-06-24 2016-06-24 GAOREPORTS-B-294944-2 machine generated eng fdlp COMPTROLLERDECISION GAOREPORTS-B-294944-2 B-294944.2 Comptroller General Decision Agency's use of a price evaluation scheme in a pharmaceutical procurement that compares prices for two drugs on a per-tablet basis is unobjectionable where the record shows that the optimal dosing level for both drugs is a single pill taken once daily, and where the agency has no valid data for estimating other dosing levels of these drugs, and does not expect other dosing levels to be ordered in significant quantities. https://www.govinfo.gov/content/pkg/GAOREPORTS-B-294944-2/html/GAOREPORTS-B-294944-2.htm https://www.govinfo.gov/content/pkg/GAOREPORTS-B-294944-2/pdf/GAOREPORTS-B-294944-2.pdf GAO/B-294944.2 https://www.govinfo.gov/app/details/GAOREPORTS-B-294944-2 Comptroller General Decision GAO/B-294944.2; Bristol-Myers Squibb Company, B-294944.2, January 18, 2005;